D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine

Fused filament fabrication (FFF) is a process used to manufacture oral forms adapted to the needs of patients. Polyethylene oxide (PEO) filaments were produced by hot melt extrusion (HME) to obtain a filament suitable for the production of amiodarone hydrochloride oral forms by FFF 3D printing. In o...

Full description

Bibliographic Details
Main Authors: Stéphane Roulon, Ian Soulairol, Maxime Cazes, Léna Lemierre, Nicolas Payre, Laurent Delbreilh, Jean Alié
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/10/3000
_version_ 1797533593926369280
author Stéphane Roulon
Ian Soulairol
Maxime Cazes
Léna Lemierre
Nicolas Payre
Laurent Delbreilh
Jean Alié
author_facet Stéphane Roulon
Ian Soulairol
Maxime Cazes
Léna Lemierre
Nicolas Payre
Laurent Delbreilh
Jean Alié
author_sort Stéphane Roulon
collection DOAJ
description Fused filament fabrication (FFF) is a process used to manufacture oral forms adapted to the needs of patients. Polyethylene oxide (PEO) filaments were produced by hot melt extrusion (HME) to obtain a filament suitable for the production of amiodarone hydrochloride oral forms by FFF 3D printing. In order to produce personalized oral forms adapted to the patient characteristics, filaments used by FFF must be controlled in terms of mass homogeneity along filament. This work highlights the relation between filament mass homogeneity and its diameter. This is why the impact of filler excipients physical properties was studied. It has been showed that the particle’s size distribution of the filler can modify the filament diameter variability which has had an impact on the mass of oral forms produced by FFF. Through this work it was shown that D-Sorbitol from Carlo Erba allows to obtain a diameter variability of less than 2% due to its unique particle’s size distribution. Using the filament produced by HME and an innovating calibration method based on the filament length, it has been possible to carry out three dosages of 125 mg, 750 mg and 1000 mg by 3D printing with acceptable mass uniformity.
first_indexed 2024-03-10T11:17:48Z
format Article
id doaj.art-1d541bc9f1b74d37abc475efcbab9cf9
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T11:17:48Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-1d541bc9f1b74d37abc475efcbab9cf92023-11-21T20:16:53ZengMDPI AGMolecules1420-30492021-05-012610300010.3390/molecules26103000D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized MedicineStéphane Roulon0Ian Soulairol1Maxime Cazes2Léna Lemierre3Nicolas Payre4Laurent Delbreilh5Jean Alié6Group of Materials Physics, UNIROUEN Normandie, INSA Rouen, CNRS, Normandie University, Av. Université, 76801 St Etienne du Rouvray, FranceDepartment of Pharmacy, Nîmes University Hospital, 30900 Nimes, FranceSolid State Characterization and 3D Printing Laboratory, SMO-A Department, Sanofi R&D, 371 rue du Pr. Joseph Blayac, 34080 Montpellier, FranceSolid State Characterization and 3D Printing Laboratory, SMO-A Department, Sanofi R&D, 371 rue du Pr. Joseph Blayac, 34080 Montpellier, FranceSolid State Characterization and 3D Printing Laboratory, SMO-A Department, Sanofi R&D, 371 rue du Pr. Joseph Blayac, 34080 Montpellier, FranceGroup of Materials Physics, UNIROUEN Normandie, INSA Rouen, CNRS, Normandie University, Av. Université, 76801 St Etienne du Rouvray, FranceSolid State Characterization and 3D Printing Laboratory, SMO-A Department, Sanofi R&D, 371 rue du Pr. Joseph Blayac, 34080 Montpellier, FranceFused filament fabrication (FFF) is a process used to manufacture oral forms adapted to the needs of patients. Polyethylene oxide (PEO) filaments were produced by hot melt extrusion (HME) to obtain a filament suitable for the production of amiodarone hydrochloride oral forms by FFF 3D printing. In order to produce personalized oral forms adapted to the patient characteristics, filaments used by FFF must be controlled in terms of mass homogeneity along filament. This work highlights the relation between filament mass homogeneity and its diameter. This is why the impact of filler excipients physical properties was studied. It has been showed that the particle’s size distribution of the filler can modify the filament diameter variability which has had an impact on the mass of oral forms produced by FFF. Through this work it was shown that D-Sorbitol from Carlo Erba allows to obtain a diameter variability of less than 2% due to its unique particle’s size distribution. Using the filament produced by HME and an innovating calibration method based on the filament length, it has been possible to carry out three dosages of 125 mg, 750 mg and 1000 mg by 3D printing with acceptable mass uniformity.https://www.mdpi.com/1420-3049/26/10/30003D printingfused filament fabricationhot melt extrusionoral dosage formsfilamentpersonalized medicine
spellingShingle Stéphane Roulon
Ian Soulairol
Maxime Cazes
Léna Lemierre
Nicolas Payre
Laurent Delbreilh
Jean Alié
D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine
Molecules
3D printing
fused filament fabrication
hot melt extrusion
oral dosage forms
filament
personalized medicine
title D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine
title_full D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine
title_fullStr D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine
title_full_unstemmed D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine
title_short D-Sorbitol Physical Properties Effects on Filaments Used by 3D Printing Process for Personalized Medicine
title_sort d sorbitol physical properties effects on filaments used by 3d printing process for personalized medicine
topic 3D printing
fused filament fabrication
hot melt extrusion
oral dosage forms
filament
personalized medicine
url https://www.mdpi.com/1420-3049/26/10/3000
work_keys_str_mv AT stephaneroulon dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine
AT iansoulairol dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine
AT maximecazes dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine
AT lenalemierre dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine
AT nicolaspayre dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine
AT laurentdelbreilh dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine
AT jeanalie dsorbitolphysicalpropertieseffectsonfilamentsusedby3dprintingprocessforpersonalizedmedicine